Interleukin-8 level in maternal serum as a marker for screening of histological chorioamnionitis at term

International Journal of Gynecology and Obstetrics

Volumn 57, Issue 2, 1997, Pages 153-159

  Shimoya, K ^a   Matsuzaki, N ^a   Taniguchi, T ^b   Okada, T ^c   Saji, F ^a   Murata, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

^c Fujimoto Hospital   (Japan)

Author keywords

Chorioamnionitis; Cytokine; IL 8; Maternal serum; Term pregnancy

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORD SERUM; FEMALE; GESTATION PERIOD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING; TITRIMETRY;

EID: 0031011121     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(97)02891-9     Document Type: Article

References (24)

1. Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992; 79: 75-80.
2. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. New Engl J Med 1988; 319: 972-978.
3. Guzick DS, Winn K. The association of chorioamnionitis with preterm delivery. Obstet Gynecol 1985; 65: 11-16.
4. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990; 75: 622-626.
5. Hollander D. Diagnosis of chorioamninitis. Clin Obstet Gynecol 1986; 25: 816-825.
6. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin-6 in preterm labor.Association with infection. J Clin Invest 1990; 85: 1392-1400.
7. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165: 813-820.
8. Blanc WA. Amniotic infection syndrome: pathogenesis, morphology and significance in circumnatal mortality. Clin Obstet Gynecol 1959; 2: 715-734.
9. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R et al. Infection and labor V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817-824.
10. Kirshon B, Rosenfeld B, Mari G, Belfort M. Amniotic fluid glucose and intrauterine infection. Am J Obstet Gynecol 1991; 164: 818-820.
11. Shimoya K, Matsuzaki N, Taniguchi T, Jo T, Saji F, Kitajima H et al. Interleukin-8 in cord sera: A sensitive and specific marker for the detection of preterm chorioamnionitis. J Infect Dis 1992; 165: 957-960.
12. Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol 1985; 151: 541-544.
13. Ernest JM, Swain M, Block SM, Nelson LH, Hatjis CG, Meis PJ. C-reactive protein: A limited test for managing patients with preterm labor or preterm rupture of membranes. Am J Obstet Gynecol 1987; 156: 449-454.
14. Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol 1994; 170: 1345-1351.
15. Taniguchi T, Matsuzaki N, Shimoya K, Neki R, Okada T, Kitajima H et al. Fetal mononuclear cells show a comparable capacity with maternal mononuclear cells to produce IL-8 in response to lipopolysaccharide in chorioamnionitis. J Reprod Immunol 1993; 23: 1-12.
16. Shimoya K, Matsuzaki N, Taniguchi T, Kameda T, Koyama M, Neki R et al. Human placenta constitutively produces interleukin-8 during pregnancy and enhance its production in intrauterine infection. Biol Reprod 1992; 47: 220-226.
17. Van-Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991; 146: 3478-3482.
18. Martich GD, Danner RL, Ceska M, Suffredini AF. Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of anti-inflammatory agents. J Exp Med 1991; 173: 1021-1024.
19. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematodes. A putative role in pathogenesis. J Immunol 1991; 147: 117-123.
20. Nakajima K, Martinez-Maza O, Hirano T, Breen EC, Nishanian PG, Salazar-Gonzalez JF et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol 1989; 142: 531-536.
21. Greig PC, Ernest JM, Teot L, Erickson M, Talley R. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients with premature labor with intact membranes. Am J Obstet Gynecol 1993; 169: 1035-1044.
22. Matsuzaki N, Saji F, Kameda T, Yoshizaki K, Okada T, Sawai K et al. In vivo and in vitro production of interleukin-6 by fetal mononuclear cells. Clin Immunol Immunopathol 1990; 55: 305-314.
23. Matsuzaki N, Taniguchi T, Shimoya K, Neki R, Okada T, Saji F et al. Placental interleukin-6 production is enhanced in intrauterine infection, but not in labor. Am J Obstet Gynecol 1993; 168: 94-97.
24. Maeda K, Matsuzaki N, Fuke S, Mitsuda N, Shimoya K, Nakayama M et al. Diagnostic value of maternal interleukin-level for determination of histologic chorioamnionitis in preterm delivery. Gynecol Obstet Invest 1997: in press.